论文部分内容阅读
目的:调查分析冠心病慢性心力衰竭患者的临床情况。方法:入选新疆喀什地区第二人民医院内二科2005年5月～2006年11月确诊的冠心病慢性心力衰竭住院病例163例,按有无心肌梗死分为冠心病有心肌梗死(A)组和冠心病无心肌梗死(B)组进行分析。结果:入选病例占同期总的冠心病心力衰竭住院病例的76.9%(163/212)。年龄45岁～89岁,平均年龄(65.60±8.50)岁。A组49例(30.1%),B组114例(69.9%),B组多于A组(χ2=25.920,P<0.01)。A组患者男性的比例多于B组,B组合并COPD比例多于A组。两组在合并糖尿病、高血压,以及心功能NYHA(Ⅲ+Ⅳ)、左心室舒张末期左室内径(LEDD)、左室射血分数(LVEF)≥45%和E/A≤1的比例的分布差异无统计学意义。A组应用洋地黄制剂、硝酸酯制剂、血管紧张素转换酶抑制剂、β-受体阻滞剂的比例高于B组。结论:冠心病住院患者以无心肌梗死型居多,但总体临床情况复杂,不论是何种类型,都应该给予足够的重视。
Objective: To investigate the clinical situation of patients with chronic heart failure of coronary heart disease. Methods: A total of 163 hospitalized cases of CHD with CHD diagnosed in the Second People’s Hospital of Kashi Prefecture in Xinjiang from May 2005 to November 2006 were divided into group A (MI) with coronary heart disease and myocardial infarction And coronary heart disease without myocardial infarction (B) group analysis. Results: The selected cases accounted for 76.9% (163/212) of the total cases of coronary heart disease and heart failure during the same period. Age 45 years old to 89 years old, the average age (65.60 ± 8.50) years old. 49 cases (30.1%) in group A, 114 cases (69.9%) in group B, and more in group B than in group A (χ2 = 25.920, P <0.01). The proportion of men in group A was more than that in group B, and the proportion of combined COPD in group B was more than that in group A. There was no significant difference between the two groups in the incidence of diabetes mellitus, hypertension, NYHA (Ⅲ + Ⅳ), left ventricular end-diastolic diameter (LVD), LVEF≥45% and E / A≤1 No significant difference in distribution. A group of digitalis preparations, nitrate preparations, angiotensin-converting enzyme inhibitors, β-blockers higher than the proportion of B group. Conclusion: There is no myocardial infarction type in coronary heart disease inpatients, but the overall clinical situation is complicated. No matter what type, all patients should pay enough attention.